1. Home
  2. AXTI vs ORMP Comparison

AXTI vs ORMP Comparison

Compare AXTI & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • ORMP
  • Stock Information
  • Founded
  • AXTI 1986
  • ORMP 2002
  • Country
  • AXTI United States
  • ORMP United States
  • Employees
  • AXTI N/A
  • ORMP N/A
  • Industry
  • AXTI Semiconductors
  • ORMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXTI Technology
  • ORMP Health Care
  • Exchange
  • AXTI Nasdaq
  • ORMP Nasdaq
  • Market Cap
  • AXTI 93.9M
  • ORMP 91.9M
  • IPO Year
  • AXTI 1998
  • ORMP N/A
  • Fundamental
  • Price
  • AXTI $2.30
  • ORMP $2.30
  • Analyst Decision
  • AXTI Strong Buy
  • ORMP Hold
  • Analyst Count
  • AXTI 5
  • ORMP 1
  • Target Price
  • AXTI $5.30
  • ORMP N/A
  • AVG Volume (30 Days)
  • AXTI 275.8K
  • ORMP 128.4K
  • Earning Date
  • AXTI 02-20-2025
  • ORMP 03-05-2025
  • Dividend Yield
  • AXTI N/A
  • ORMP N/A
  • EPS Growth
  • AXTI N/A
  • ORMP N/A
  • EPS
  • AXTI N/A
  • ORMP 0.11
  • Revenue
  • AXTI $94,685,000.00
  • ORMP N/A
  • Revenue This Year
  • AXTI $32.13
  • ORMP N/A
  • Revenue Next Year
  • AXTI $12.84
  • ORMP N/A
  • P/E Ratio
  • AXTI N/A
  • ORMP $20.65
  • Revenue Growth
  • AXTI 15.24
  • ORMP N/A
  • 52 Week Low
  • AXTI $1.73
  • ORMP $2.00
  • 52 Week High
  • AXTI $5.64
  • ORMP $3.67
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 53.90
  • ORMP 41.44
  • Support Level
  • AXTI $2.13
  • ORMP $2.37
  • Resistance Level
  • AXTI $2.46
  • ORMP $2.36
  • Average True Range (ATR)
  • AXTI 0.14
  • ORMP 0.06
  • MACD
  • AXTI 0.02
  • ORMP -0.01
  • Stochastic Oscillator
  • AXTI 65.96
  • ORMP 20.00

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single-element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Share on Social Networks: